newsfilter
← Latest News
GlobeNewswire·

Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Differentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth HOUSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial-stage medical